Celebrating 20 Years of MMS
MMS has spent 20 years applying data-led judgment and scientific rigor to help therapies reach patients faster and more responsibly.
MMS has always been strongest in the moments where there is no clear playbook, whether that’s biosimilars, emerging therapeutic areas like psychedelics, rare and orphan conditions, or global data harmonization. When there is no map, we draw one.
MMS was founded on people and purpose. For 20 years, we’ve focused on scientific excellence, data-led decisions, and genuine partnership because getting the evidence right is what ultimately gets therapies to patients.
How MMS Began: Built for People, Driven by Purpose
One clear direction. For 20 years.
MMS was founded in 2006 with a clear point of view. Exceptional people deserve an environment where they can thrive, and data should sit at the center of every decision in clinical development.
At a time when clinical data was expanding faster than the insight drawn from it, MMS was built to collaborate with sponsors as a true scientific partner. We apply judgment and experience to ensure data integrity and regulatory confidence from trial design to submission and beyond.
That founder-led vision shaped the MMS of today: a globally trusted CRO, defined by innovation, cultural excellence, and real-world impact.
Suggested For You
perspectives
March 12th, 2026
AI in Pharma: Autopilot Is Not the Same as Removing the Pilot
webinar
April 16th, 2026
Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors
perspectives
March 3rd, 2026
Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design
perspectives
February 25th, 2026
Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency
perspectives
February 10th, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
news
February 5th, 2026
MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions
perspectives
February 3rd, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
news
January 29th, 2026
Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards
ebook
January 27th, 2026
A Practical Guide to Expedited Regulatory Pathways
perspectives
January 27th, 2026
What Regulators Want to See in Surrogate Endpoints Today
perspectives
January 20th, 2026
Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration
perspectives
January 13th, 2026
Making Clinical Trial Technology Work in Practice